title: Stability and transport of cervical cytobrushes for isolation of mononuclear cells from the female genital tract.
abstract: Cervical cytobrushing, biopsy, or lavages have previously been used to collect mononuclear cells from the female genital tract. Compared with blood, obtaining cells from the female genital tract is more invasive and generally yields few cells for subsequent immune studies. Because of the value of including mucosal sampling in HIV vaccine trials, standardisation of methods for collection, processing, and analysis of immunity from cells derived from the female genital tract is important. The aim of this study was to assess the effect of transport conditions on the viability, recovery and antigenic responsiveness of cervical T cells. This was investigated in cervical cytobrush specimens collected from 215 chronically HIV-infected women. Cytobrushes were either processed immediately, after cryopreservation, or after 24h at 37°C, 4°C or room temperature. CD3(+) T cell numbers were quantified using Guava automated cell counting. Viability was assessed using Trypan and Annexin/PI staining. Intracellular cytokine staining was used to evaluate IFN-γ responses to PMA, PHA and CEF peptides in cytobrush-derived T cells ex vivo and after delayed processing. In vitro polyclonal expansion of thawed cervical lymphocytes was conducted for 14days in the presence of anti-CD3 and IL-2. We found that CD3(+) T cell recovery and viability was similar in cytobrushes processed immediately or after 24h irrespective of the conditions at which they were maintained. Fifty percent of the CD3(+) T cells could be recovered after cryopreservation of cytobrushes and these could be polyclonally expanded in half of the cryopreserved samples. IFN-γ production following mitogenic stimulation was similar in ex vivo and delayed processing cytobrushes. Maintaining cytobrushes at 37°C prior to processing significantly improved the detection of CEF-specific T cell responses compared to ex vivo. We conclude that cervical cytobrush-derived T cells are robust and can preserve their viability, phenotype and function over 24h of mock transport.
authors.affiliation: Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town, South Africa.
authors.forename: Lenine J
authors.initials: LJ
authors.lastname: Liebenberg
authors.forename: Hoyam
authors.initials: H
authors.lastname: Gamieldien
authors.forename: Nonhlanhla N
authors.initials: NN
authors.lastname: Mkhize
authors.forename: Shameem Z
authors.initials: SZ
authors.lastname: Jaumdally
authors.forename: Pam P
authors.initials: PP
authors.lastname: Gumbi
authors.forename: Lynette
authors.initials: L
authors.lastname: Denny
authors.forename: Jo-Ann S
authors.initials: JA
authors.lastname: Passmore
mesh_terms: D000328:Adult; D002469:Cell Separation / Q000379:methods*; D002470:Cell Survival; D002584:Cervix Uteri / Q000166:cytology* / Q000276:immunology; D015925:Cryopreservation; D005260:Female; D015658:HIV Infections / Q000276:immunology; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis; D018655:Lymphocyte Count; D013048:Specimen Handling; D013601:T-Lymphocytes / Q000166:cytology* / Q000276:immunology
chemical_list: D007371:Interferon-gamma